Search results for "Sclerosis"

showing 10 items of 1583 documents

Sense of Coherence and Health-Related Quality of Life in Patients with Multiple Sclerosis: The Role of Physical and Neurological Disability

2022

Multiple sclerosis is a progressive demyelinating disease of the central nervous system that can lead to permanent disability and significantly impact the quality of life. The present study explores the relationship between neurological disability and disease symptoms, quality of life, and the level of sense of coherence, which is an important resource for coping with the disease. EDSS, GNDS, SOC-29, and MSIS-29 were used in the presented study. The study group consisted of 137 people diagnosed with multiple sclerosis. The study showed the correlation between most of the analyzed variables. Mood disability and fatigue were significant predictors of the sense of coherence and explained 34% o…

multiple sclerosis; physical disability; neurological disability; sense of coherence; quality of lifeGeneral MedicineJournal of Clinical Medicine
researchProduct

"Verkoston pauloissa" : MS-potilaiden kokemuksia tukiverkoston kohtaamisesta kuntoutusprosessin aikana

1998

multippeliskleroosirehabilitation processtukiverkostomultiple sclerosis diseasekuntoutusprosessifenomenologiaphenomenologyrehabilitantsocial- and health networkkuntoutuja
researchProduct

Manometric assessment of oesophageal involvement in progressive systemic sclerosis, morphoea and Raynaud's disease.

1982

SUMMARY Oesophageal function was studied by radiography and manometry in fifty-one patients with progressive systemic sclerosis (PSS), fourteen patients with morphoea, twelve patients with Raynaud's disease and twenty-one normal subjects. Upper oesophageal sphincter pressure was not affected. Peristaltic contractions of the upper third of the oesophagus were significantly decreased in PSS and morphoea, but the lower two-thirds were affected only in PSS. Lower oesophageal sphincter pressure was significantly decreased in PSS but was normal in morphoea and Raynaud's disease. There was a significant correlation between oesophageal dysfunction and the duration of PSS. Manometry was better than …

musculoskeletal diseasesAdultMalemedicine.medical_specialtyTime FactorsOesophageal manometryAdolescentManometryRadiographyDermatologySkin DiseasesScleroderma LocalizedEsophagusstomatognathic systemLower oesophageal sphincter pressurePressureMedicineUpper oesophageal sphincter pressureHumansAgedScleroderma Systemicbusiness.industryProgressive systemic sclerosisRaynaud DiseaseMiddle Agedmedicine.diseaseeye diseasesRadiographystomatognathic diseasesRaynaud's diseaseFemaleUpper thirdRadiologyOesophageal functionbusinessThe British journal of dermatology
researchProduct

An update on the relationships between rheumatoid arthritis and atherosclerosis

2010

Rheumatoid arthritis is a chronic inflammatory disease. Cardiovascular events are the most important cause of mortality and morbidity in patients with rheumatoid arthritis. Beyond the traditional cardiovascular risk factors, chronic systemic inflammation has been shown to be a crucial factor in atherosclerosis development and progression from endothelial dysfunction to plaque rupture and thrombosis. Many studies have shown that atherosclerosis is not a passive event like accumulation of lipids in the vessel walls; by contrast, it represents an active inflammation of the vessels. Inflammatory cells such as macrophages, monocytes and T cells play important roles in the development of both rhe…

musculoskeletal diseasesT-LymphocytesAtherosclerosis Rheumatoid arthritis Inflammation Cardiovascular risk10265 Clinic for Endocrinology and DiabetologyInflammation610 Medicine & healthComorbiditySystemic inflammationModels BiologicalMonocytes2705 Cardiology and Cardiovascular MedicineArthritis RheumatoidRisk FactorsImmunopathologymedicineHumansEndothelial dysfunctionAutoimmune diseaseInflammationbusiness.industryVascular diseaseMacrophagesmedicine.diseaseAtherosclerosisThrombosisOxidative StressCardiovascular DiseasesRheumatoid arthritisImmunologyDisease Progressionmedicine.symptomInsulin ResistanceCardiology and Cardiovascular Medicinebusiness
researchProduct

Looking for the best therapeutical stretegy after the 24th natalizumab adiministretion. The TY-STOP study

2012

natalizumab multiple sclerosis
researchProduct

Clinical and Sociodemographic Variables and the Level of Social Support in People with Multiple Sclerosis

2019

Wstęp. Stwardnienie rozsiane (SM) jest przewlekłą, postępującą neurologiczną chorobą, która może prowadzić do znacznej niepełnosprawności. Istotnym zasobem w radzeniu sobie z SM i innymi chorobami przewlekłymi jest wsparcie społeczne.Cel. Celem badań było określenie związku pomiędzy zmiennymi klinicznymi i socjodemograficznymi a wsparciem społecznym u osób z SM.Materiał i metody. W badaniu wykorzystano Rozszerzoną Skalę Niewydolności Ruchowej (EDSS), Skalę Niepełnosprawności Neurologicznej Szpitala Guy (GNDS) oraz Berlińskie Skale Wsparcia Społecznego Grupę badaną stanowiło 137 osób ze zdiagnozowanym SM.Wyniki. Spostrzegane wsparcie społeczne nie jest powiązane ze zmiennymi klinicznymi, tak…

niepełnosprawnośćbusiness.industryMultiple sclerosiswsparcie społeczneProfessional supportDiseasestwardnienie rozsianemedicine.diseaseSocial supportMood disordersScale (social sciences)medicineMarital statusGeneral Agricultural and Biological SciencesbusinessCognitive impairmentClinical psychologyThe Journal of Neurological and Neurosurgical Nursing
researchProduct

Study of the mechanisms of oxidative stress, mitochondrial function and endoplasmic reticulum stress in obesity. Role in subclinical atherosclerosis …

2019

El aumento alarmante de la prevalencia de obesidad a nivel mundial y la enorme carga de enfermedad asociada ha generado una creciente demanda de estrategias para frenar la epidemia y / o mitigar los efectos dañinos de la obesidad sobre la salud. Para ello se requiere un compromiso firme y sinérgico por parte de todas las fuerzas sociales, no sólo para desarrollar estrategias preventivas, sino también para contribuir al conocimiento de los eventos patológicos y los mecanismos involucrados en el desarrollo de esta enfermedad. Por ello, el objetivo principal de la presente tesis doctoral es profundizar en los mecanismos subyacentes de la obesidad, especialmente en aquellos relacionados con el …

obesityleukocytes activationUNESCO::CIENCIAS DE LA VIDA::Biología molecularchronic periodontitis:CIENCIAS MÉDICAS ::Medicina interna::Endocrinología [UNESCO]pinitolendothelial dysfunction:CIENCIAS DE LA VIDA::Biología molecular [UNESCO]mitochondriaUNESCO::CIENCIAS MÉDICAS ::Patología::Arteriosclerosisinflammationcardiovascular diseasebotanical compoundsoxidative stresscaloric restriction:CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología endocrina [UNESCO]:CIENCIAS MÉDICAS ::Patología::Arteriosclerosis [UNESCO]metabolismUNESCO::CIENCIAS MÉDICAS ::Medicina interna::EndocrinologíaUNESCO::CIENCIAS DE LA VIDA::Fisiología humana ::Fisiología endocrina
researchProduct

Intermittent Fasting and the Possible Benefits in Obesity, Diabetes, and Multiple Sclerosis: A Systematic Review of Randomized Clinical Trials

2021

Intermittent fasting has become popular in recent years and is controversially presented as a possible therapeutic adjunct. A bibliographic review of the literature on intermittent fasting and obesity, diabetes, and multiple sclerosis was carried out. The scientific quality of the methodology and the results obtained were evaluated in pairs. Intermittent fasting has beneficial effects on the lipid profile, and it is associated with weight loss and a modification of the distribution of abdominal fat in people with obesity and type 2 diabetes as well as an improvement in the control of glycemic levels. In patients with multiple sclerosis, the data available are too scarce to draw any firm con…

obesitymedicine.medical_specialtyMultiple SclerosisGlycemic ControlReviewType 2 diabeteslaw.inventionRandomized controlled trialWeight losslawDiabetes mellitusIntermittent fastingHumansMedicineTX341-641Intensive care medicineRandomized Controlled Trials as TopicGlycemicNutrition and Dieteticsexercisemedicine.diagnostic_testNutrition. Foods and food supplyintermittent fastingbusiness.industryFastingmedicine.diseaseObesityDiabetes Mellitus Type 2type 2 diabetesmedicine.symptombusinessLipid profileFood ScienceNutrients
researchProduct

Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS.

2005

Phosphorylated p38 mitogen-activated protein kinase (p38MAPK), but not activated c-jun-N-terminal kinase (JNK), increases in the motor neurons of transgenic mice overexpressing ALS-linked SOD1 mutants at different stages of the disease. This effect is associated with a selective increase of phosphorylated MKK3-6, MKK4 and ASK1 and a concomitant upregulation of the TNFalpha receptors (TNFR1 and TNFR2), but not IL1beta and Fas receptors. Activation of both p38 MAPK and JNK occurs in the activated microglial cells of SOD1 mutant mice at the advanced stage of the disease; however, this effect is not accompanied by the concomitant activation of the upstream kinases ASK1 and MKK3,4,6, while both …

p38 mitogen-activated protein kinasesMAP Kinase Kinase 3Mice TransgenicMAP Kinase Kinase 6BiologyMAP Kinase Kinase Kinase 5p38 Mitogen-Activated Protein KinasesReceptors Tumor Necrosis FactorCellular and Molecular NeuroscienceMiceSuperoxide Dismutase-1Downregulation and upregulationAnimalsHumansASK1RNA Messengerfas ReceptorPhosphorylationReceptorProtein kinase AMolecular BiologyP38MAPK cascadeMotor NeuronsKinaseSuperoxide DismutaseTumor Necrosis Factor-alphaAmyotrophic Lateral SclerosisJNK Mitogen-Activated Protein KinasesReceptors Interleukin-1Cell BiologyCell biologyEnzyme ActivationMice Inbred C57BLDisease Models AnimalTumor Necrosis Factor Decoy ReceptorsSpinal CordReceptors Tumor Necrosis Factor Type IDisease ProgressionTumor necrosis factor alphaSignal TransductionMolecular and cellular neurosciences
researchProduct

Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis.

2018

Multiple sclerosis (MS) is a chronic inflammatory disease with demyelination of the central nervous system. High-dosage corticosteroids are the first-line therapy in the acute relapsing of MS. We report a case of severe high-dose methylprednisolone-induced acute hepatitis in a patient with a new diagnosis of MS. A 16-year-old girl was admitted for urticaria, angioedema, nausea and vomiting a month later she had been diagnosed with MS and treated with high-dosage methylprednisolone. Laboratory investigations showed hepatic insufficiency with grossly elevated liver enzymes. A liver biopsy showed focal centrilobular hepatocyte necrosis with interface hepatitis. Methylprednisolone-induced hepat…

paediatrics (drugs And Medicines)safetymedicine.medical_specialtyMultiple SclerosisAdolescentNauseaAnti-Inflammatory AgentsGastroenterologyMethylprednisoloneDiagnosis Differential03 medical and health sciencesLiver disease0302 clinical medicineInternal medicinemedicineHumansunwanted effects/adverse reactionsGlucocorticoidsmedicine.diagnostic_testAngioedemabusiness.industryMultiple sclerosisGeneral Medicinemedicine.diseaseMethylprednisolonePulse Therapy DrugLiver biopsyVomitingSettore MED/26 - Neurologia030211 gastroenterology & hepatologyFemaleDifferential diagnosismedicine.symptomChemical and Drug Induced Liver Injuryliver diseasebusiness030217 neurology & neurosurgerymedicine.drugFindings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse EffectBMJ case reports
researchProduct